GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

Ucb UCB.BR · EUR

Health Care · Euronext Brussels · 🇧🇪 Belgium

Compare

298.80

+2.72%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

26 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 18Buy
  • 4Hold
  • 0Sell
  • 2Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Last close 298.80Average target 275.68

Low
214.12
Average
275.68
Median
280.50
High
325.50

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue€8.94bn€9.92bn€11.00bn€12.12bn€12.97bn
Revenue, highest€9.63bn€11.29bn€12.94bn€13.63bn€14.59bn
Revenue, lowest€8.51bn€9.34bn€10.19bn€11.42bn€12.22bn
Earnings per share12.7014.7117.4821.7624.72
Earnings per share, highest15.3217.4521.3225.2828.72
Earnings per share, lowest10.7313.3614.7620.1222.85
Analysts161615107

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q4 2025Q2 2025Q4 2024Q2 2024Q1 2024Q4 2023
Forecast5.035.493.562.741.721.361.35
Reported6.776.463.532.892.091.581.57
Difference+34.6%+17.6%-0.8%+5.6%+21.7%+16.2%+16.0%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

7 / 10

Revenue growth 7.2% a year over 10 years. Return on equity 14.3%.

Model fair value

284.45

From earnings 284.45, from revenue 212.65.

Piotroski score

5 / 9

A nine-point test of financial strength, for 31 Dec 2024.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.